Meet Moderna's Surprising New COVID Vaccine Partner
In a remarkably short period of time, Moderna (NASDAQ: MRNA) has become a household name among Americans. The company's COVID-19 vaccine mRNA-1273 became the second to win U.S. emergency use authorization in December. Since then, millions of individuals have received the vaccine. And Moderna's shares have skyrocketed.
Rolling out vaccines on a massive scale isn't something that a biotech that previously had no products on the market can do by itself. Moderna has turned to other companies for assistance. But you might be surprised to learn who Moderna's new COVID vaccine partner is.
Image source: Getty Images.
Source Fool.com
